These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7030018)

  • 1. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].
    Kitazawa Y; Azuma I; Takase M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):798-804. PubMed ID: 7030018
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pilocarpine, carbachol and carteolol on open-angle glaucoma and ocular hypertension (author's transl)].
    Ishikawa T; Okisaka S; Hiwatari S; Taketani P; Sugimachi Y
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):837-42. PubMed ID: 7304355
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H; Tournoux A; Martenet AC
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma].
    van Husen H
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):491-5. PubMed ID: 3550260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE; Becker H; Fuchs HB
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 12-hour control of intraocular pressure on carteolol 2% twice daily.
    Duff GR; Newcombe RG
    Br J Ophthalmol; 1988 Dec; 72(12):890-1. PubMed ID: 3067744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.
    Stewart WC; Shields MB; Allen RC; Lewis RA; Cohen JS; Hoskins HD; Hetherington JN; Bahr RL; Noblin JE; Delehanty JT
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):258-61. PubMed ID: 1869063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ohno S; Ichiishi A; Matsuda H
    Ophthalmologica; 1989; 199(1):41-5. PubMed ID: 2761985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carteolol: preliminary study on ocular pressure-reducing action.
    Gorgone G; Spina F; Amantia L
    Ophthalmologica; 1983; 187(3):171-3. PubMed ID: 6355953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-masked comparison of carteolol and timolol in ocular hypertension.
    Scoville B; Mueller B; White BG; Krieglstein GK
    Am J Ophthalmol; 1988 Feb; 105(2):150-4. PubMed ID: 3277436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
    Yasar T; Ozdemir M; Andi I; Ozdemir G; Simsek S
    Jpn J Ophthalmol; 2004; 48(2):172-3. PubMed ID: 15060799
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study between timolol and d-epinephrine in the treatment of open-angle glaucoma (author's transl)].
    Merkle W
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):203-5. PubMed ID: 7014999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with timolol in treatment of glaucoma (author's transl)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Aug; 173(2):202-7. PubMed ID: 359904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.
    Duff GR; Graham PA
    Br J Ophthalmol; 1988 Jan; 72(1):27-8. PubMed ID: 3277664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new beta-blockers for glaucoma.
    Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.